Literature DB >> 21822130

Ocular allergy.

Mitchell H Friedlaender1.   

Abstract

PURPOSE OF REVIEW: Ocular allergy is often encountered by allergists, ophthalmologists, pediatricians, and primary care physicians. An understanding of the immunologic mechanisms, the differential diagnosis, the clinical features, and the treatment of ocular allergy will be useful to all physicians who encounter these patients. RECENT
FINDINGS: Basic and clinical research has provided a better understanding of the cells, mediators, and immunologic events which occur in ocular allergy. New pharmacological agents, including more potent mast cell stabilizers, and low-dose corticosteroids, have improved the efficacy and safety of ocular allergy treatment.
SUMMARY: Physicians who currently treat ocular allergy have a greater familiarity with the signs and symptoms of allergic disease, a better understanding of the mechanisms and clinical features of allergic conjunctivitis, and improved therapeutic tools to deliver satisfactory outcomes in the management of ocular allergy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21822130     DOI: 10.1097/ACI.0b013e32834a9652

Source DB:  PubMed          Journal:  Curr Opin Allergy Clin Immunol        ISSN: 1473-6322


  10 in total

1.  Topical loteprednol etabonate 0.5 % for treatment of vernal keratoconjunctivitis: efficacy and safety.

Authors:  Veysi Oner; Fatih Mehmet Türkcü; Mehmet Taş; Mehmet Fuat Alakuş; Yalçın Işcan
Journal:  Jpn J Ophthalmol       Date:  2012-05-25       Impact factor: 2.447

2.  Evaluation of allergic sensitization in Lebanese patients with allergic conjunctivitis.

Authors:  Nicolas Arej; Carla Irani; Youssef Abdelmassih; Elise Slim; Joelle Antoun; Riad Bejjani; Alexandre Schakal; Naji Waked
Journal:  Int Ophthalmol       Date:  2017-08-22       Impact factor: 2.031

Review 3.  T helper subsets in allergic eye disease.

Authors:  Nancy J Reyes; Daniel R Saban
Journal:  Curr Opin Allergy Clin Immunol       Date:  2014-10

4.  Treatment of asymmetrical vernal keratoconjunctivitis with supratarsal corticosteroid injection.

Authors:  Onsiri Thanathanee; Chavakij Bhoomibunchoo; Olan Suwan-apichon
Journal:  BMJ Case Rep       Date:  2014-11-19

Review 5.  Current Knowledge in Allergic Conjunctivitis.

Authors:  Beatriz Vidal Villegas; Jose Manuel Benitez-Del-Castillo
Journal:  Turk J Ophthalmol       Date:  2021-02-25

6.  Patient and public involvement in mobile health-based research for hay fever: a qualitative study of patient and public involvement implementation process.

Authors:  Kenta Fujio; Takenori Inomata; Kumiko Fujisawa; Jaemyoung Sung; Masahiro Nakamura; Masao Iwagami; Kaori Muto; Nobuyuki Ebihara; Masahiro Nakamura; Mitsuhiro Okano; Yasutsugu Akasaki; Yuichi Okumura; Takuma Ide; Shuko Nojiri; Masashi Nagao; Keiichi Fujimoto; Kunihiko Hirosawa; Akira Murakami
Journal:  Res Involv Engagem       Date:  2022-09-02

7.  Turkish Guideline for Diagnosis and Treatment of Allergic Rhinitis (ART).

Authors:  Mustafa Cenk Ecevit; Müge Özcan; İlknur Haberal Can; Emel Çadallı Tatar; Serdar Özer; Erkan Esen; Doğan Atan; Sercan Göde; Çağdaş Elsürer; Aylin Eryılmaz; Berna Uslu Coşkun; Zahide Mine Yazıcı; Mehmet Emre Dinç; Fatih Özdoğan; Kıvanç Günhan; Nagihan Bilal; Arzu Yasemin Korkut; Fikret Kasapoğlu; Bilge Türk; Ela Araz Server; Özlem Önerci Çelebi; Tuğçe Şimşek; Rauf Oğuzhan Kum; Mustafa Kemal Adalı; Erdem Eren; Nesibe Gül Yüksel Aslıer; Tuba Bayındır; Aslı Çakır Çetin; Ayşe Enise Göker; Işıl Adadan Güvenç; Sabri Köseoğlu; Gül Soylu Özler; Ethem Şahin; Aslı Şahin Yılmaz; Ceren Güne; Gökçe Aksoy Yıldırım; Bülent Öca; Mehmet Durmuşoğlu; Yunus Kantekin; Süay Özmen; Gözde Orhan Kubat; Serap Köybaşı Şanal; Emine Elif Altuntaş; Adin Selçuk; Haşmet Yazıcı; Deniz Baklacı; Atılay Yaylacı; Deniz Hancı; Sedat Doğan; Vural Fidan; Kemal Uygur; Nesil Keleş; Cemal Cingi; Bülent Topuz; Salih Çanakçıoğlu; Metin Önerci
Journal:  Turk Arch Otorhinolaryngol       Date:  2021-05

Review 8.  Allergic conjunctivitis: a comprehensive review of the literature.

Authors:  Mario La Rosa; Elena Lionetti; Michele Reibaldi; Andrea Russo; Antonio Longo; Salvatore Leonardi; Stefania Tomarchio; Teresio Avitabile; Alfredo Reibaldi
Journal:  Ital J Pediatr       Date:  2013-03-14       Impact factor: 2.638

9.  Central corneal thickness in patients with atopic keratoconjunctivitis.

Authors:  Osman Ondas; Sadullah Keles
Journal:  Med Sci Monit       Date:  2014-09-21

10.  Pharmacokinetics and safety of olopatadine hydrochloride 0.77% in healthy subjects with asymptomatic eyes: data from 2 independent clinical studies.

Authors:  Edward Meier; Abhijit Narvekar; Ganesh R Iyer; Harvey B DuBiner; Apinya Vutikullird; David Wirta; Kenneth Sall
Journal:  Clin Ophthalmol       Date:  2017-04-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.